<!DOCTYPE html>
<html lang="zh-CN">
<head>
  <meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=2">
<meta name="theme-color" content="#222">
<meta name="generator" content="Hexo 6.0.0">
  <link rel="apple-touch-icon" sizes="180x180" href="/images/apple-touch-icon-next.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/images/favicon-32x32-next.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/images/favicon-16x16-next.png">
  <link rel="mask-icon" href="/images/logo.svg" color="#222">

<link rel="stylesheet" href="/css/main.css">


<link rel="stylesheet" href="/lib/font-awesome/css/all.min.css">

<script id="hexo-configurations">
    var NexT = window.NexT || {};
    var CONFIG = {"hostname":"lysp2017.github.io","root":"/","scheme":"Muse","version":"7.8.0","exturl":false,"sidebar":{"position":"right","display":"post","padding":18,"offset":12,"onmobile":false},"copycode":{"enable":false,"show_result":false,"style":null},"back2top":{"enable":true,"sidebar":false,"scrollpercent":false},"bookmark":{"enable":false,"color":"#222","save":"auto"},"fancybox":false,"mediumzoom":false,"lazyload":false,"pangu":false,"comments":{"style":"tabs","active":null,"storage":true,"lazyload":false,"nav":null},"algolia":{"hits":{"per_page":10},"labels":{"input_placeholder":"Search for Posts","hits_empty":"We didn't find any results for the search: ${query}","hits_stats":"${hits} results found in ${time} ms"}},"localsearch":{"enable":true,"trigger":"auto","top_n_per_article":1,"unescape":false,"preload":false},"motion":{"enable":true,"async":false,"transition":{"post_block":"fadeIn","post_header":"slideDownIn","post_body":"slideDownIn","coll_header":"slideLeftIn","sidebar":"slideUpIn"}},"path":"search.xml"};
  </script>

  <meta name="description" content="说明： 1. 翻译自Gregory B. Lim(Chief Editor, Nature Reviews Cardiology).Era of the NOACs,nature reviews cardiology,14 December 2017.  自美国FDA首次批准华法林上市使用以来，在过去五十多年里，华法林是美国唯一可用的主流口服抗凝药。虽然维生素K拮抗剂（VKAs）已被证明对预防血">
<meta property="og:type" content="article">
<meta property="og:title" content="抗凝药物发展史中的14个里程碑（十）：NOAC的时代">
<meta property="og:url" content="http://lysp2017.github.io/2019/01/04/Era-of-the-NOACs/index.html">
<meta property="og:site_name" content="高山流水">
<meta property="og:description" content="说明： 1. 翻译自Gregory B. Lim(Chief Editor, Nature Reviews Cardiology).Era of the NOACs,nature reviews cardiology,14 December 2017.  自美国FDA首次批准华法林上市使用以来，在过去五十多年里，华法林是美国唯一可用的主流口服抗凝药。虽然维生素K拮抗剂（VKAs）已被证明对预防血">
<meta property="og:locale" content="zh_CN">
<meta property="article:published_time" content="2019-01-04T12:59:38.000Z">
<meta property="article:modified_time" content="2019-01-05T02:15:10.000Z">
<meta property="article:author" content="Louyan">
<meta property="article:tag" content="利伐沙班">
<meta property="article:tag" content="达比加群">
<meta property="article:tag" content="阿哌沙班">
<meta property="article:tag" content="依度沙班">
<meta property="article:tag" content="NOAC">
<meta name="twitter:card" content="summary">

<link rel="canonical" href="http://lysp2017.github.io/2019/01/04/Era-of-the-NOACs/">


<script id="page-configurations">
  // https://hexo.io/docs/variables.html
  CONFIG.page = {
    sidebar: "",
    isHome : false,
    isPost : true,
    lang   : 'zh-CN'
  };
</script>

  <title>抗凝药物发展史中的14个里程碑（十）：NOAC的时代 | 高山流水</title>
  






  <noscript>
  <style>
  .use-motion .brand,
  .use-motion .menu-item,
  .sidebar-inner,
  .use-motion .post-block,
  .use-motion .pagination,
  .use-motion .comments,
  .use-motion .post-header,
  .use-motion .post-body,
  .use-motion .collection-header { opacity: initial; }

  .use-motion .site-title,
  .use-motion .site-subtitle {
    opacity: initial;
    top: initial;
  }

  .use-motion .logo-line-before i { left: initial; }
  .use-motion .logo-line-after i { right: initial; }
  </style>
</noscript>

<!-- hexo injector head_end start -->
<link rel="stylesheet" href="/custom_css_source.css">
<!-- hexo injector head_end end --></head>

<body itemscope itemtype="http://schema.org/WebPage">
  <div class="container use-motion">
    <div class="headband"></div>

    <header class="header" itemscope itemtype="http://schema.org/WPHeader">
      <div class="header-inner"><div class="site-brand-container">
  <div class="site-nav-toggle">
    <div class="toggle" aria-label="切换导航栏">
      <span class="toggle-line toggle-line-first"></span>
      <span class="toggle-line toggle-line-middle"></span>
      <span class="toggle-line toggle-line-last"></span>
    </div>
  </div>

  <div class="site-meta">

    <a href="/" class="brand" rel="start">
      <span class="logo-line-before"><i></i></span>
      <h1 class="site-title">高山流水</h1>
      <span class="logo-line-after"><i></i></span>
    </a>
      <p class="site-subtitle" itemprop="description">但问耕耘，莫问收获</p>
  </div>

  <div class="site-nav-right">
    <div class="toggle popup-trigger">
        <i class="fa fa-search fa-fw fa-lg"></i>
    </div>
  </div>
</div>




<nav class="site-nav">
  <ul id="menu" class="main-menu menu">
        <li class="menu-item menu-item-home">

    <a href="/" rel="section"><i class="fa fa-home fa-fw"></i>首页</a>

  </li>
        <li class="menu-item menu-item-about">

    <a href="/about/" rel="section"><i class="fa fa-user fa-fw"></i>关于</a>

  </li>
        <li class="menu-item menu-item-tags">

    <a href="/tags/" rel="section"><i class="fa fa-tags fa-fw"></i>标签</a>

  </li>
        <li class="menu-item menu-item-categories">

    <a href="/categories/" rel="section"><i class="fa fa-th fa-fw"></i>分类</a>

  </li>
        <li class="menu-item menu-item-archives">

    <a href="/archives/" rel="section"><i class="fa fa-archive fa-fw"></i>归档</a>

  </li>
      <li class="menu-item menu-item-search">
        <a role="button" class="popup-trigger"><i class="fa fa-search fa-fw"></i>搜索
        </a>
      </li>
  </ul>
</nav>



  <div class="search-pop-overlay">
    <div class="popup search-popup">
        <div class="search-header">
  <span class="search-icon">
    <i class="fa fa-search"></i>
  </span>
  <div class="search-input-container">
    <input autocomplete="off" autocapitalize="off"
           placeholder="搜索..." spellcheck="false"
           type="search" class="search-input">
  </div>
  <span class="popup-btn-close">
    <i class="fa fa-times-circle"></i>
  </span>
</div>
<div id="search-result">
  <div id="no-result">
    <i class="fa fa-spinner fa-pulse fa-5x fa-fw"></i>
  </div>
</div>

    </div>
  </div>

</div>
    </header>

    
  <div class="back-to-top">
    <i class="fa fa-arrow-up"></i>
    <span>0%</span>
  </div>


    <main class="main">
      <div class="main-inner">
        <div class="content-wrap">
          

          <div class="content post posts-expand">
            

    
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="http://lysp2017.github.io/2019/01/04/Era-of-the-NOACs/">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="/images/avatar.gif">
      <meta itemprop="name" content="Louyan">
      <meta itemprop="description" content="">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="高山流水">
    </span>
      <header class="post-header">
        <h1 class="post-title" itemprop="name headline">
          抗凝药物发展史中的14个里程碑（十）：NOAC的时代
        </h1>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>

              <time title="创建时间：2019-01-04 20:59:38" itemprop="dateCreated datePublished" datetime="2019-01-04T20:59:38+08:00">2019-01-04</time>
            </span>
              <span class="post-meta-item">
                <span class="post-meta-item-icon">
                  <i class="far fa-calendar-check"></i>
                </span>
                <span class="post-meta-item-text">更新于</span>
                <time title="修改时间：2019-01-05 10:15:10" itemprop="dateModified" datetime="2019-01-05T10:15:10+08:00">2019-01-05</time>
              </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/%E4%BA%BA%E7%89%A9%E4%B8%8E%E5%8E%86%E5%8F%B2/" itemprop="url" rel="index"><span itemprop="name">人物与历史</span></a>
                </span>
            </span>

          

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
        <blockquote>
<p>说明：<br> 1. 翻译自Gregory B. Lim(Chief Editor, Nature Reviews
Cardiology).Era of the NOACs,nature reviews cardiology,14 December
2017.</p>
</blockquote>
<p>自美国FDA首次批准华法林上市使用以来，在过去五十多年里，华法林是美国唯一可用的主流口服抗凝药。虽然维生素K拮抗剂（VKAs）已被证明对预防血栓栓塞非常有效，但它们的使用受限于需要频繁监测和调整剂量，以及潜在的食物和药物相互作用。</p>
<p>为了解决这些局限性，开发了一类新的抗凝物（称为非VKA口服抗凝药或NOACs），其目的是至少与传统抗凝药一样有效，但具有更实用的特性（如口服给药，无需常规监测或调整剂量）。</p>
<p>与VKA(抑制依赖维生素K的凝血蛋白的生成)不同，NOAC靶向凝血级联反应中的特定凝血因子（Xa因子或凝血酶）。目前，已经有4种NOAC被批准用于治疗多种血栓性疾病，即达比加群、利伐沙班、阿哌沙班和依度沙班。</p>
<p><img
src="https://picture1-1257930107.cos.ap-shanghai.myqcloud.com/2019-01-05-%E5%B1%8F%E5%B9%95%E5%BF%AB%E7%85%A7%202019-01-05%20%E4%B8%8A%E5%8D%8810.11.58.png" /></p>
<p>自华法林以来，达比加群酯(Dabigatran
etexilate)是第一个获得长期适应症并上市的NOAC。达比加群(Dabigatran)以浓度依赖性和竞争性方式抑制血凝块的结合和游离凝血酶。</p>
<p>对2007年至2009年发表的RE-MODEL、RE-MOBILIZE和RE-NOVATE试验的汇总分析(pooled
analysis)显示，达比加群在膝关节或髋关节置换术后血栓预防方面至少与依诺肝素(enoxaparin)等效。</p>
<p>RE-COVER
I和II试验显示，达比加群对于治疗急性VTE的疗效不劣于华法林。</p>
<p>2009年的RE-LY研究纳入了18,000例房颤患者，结果表明在卒中和全身性栓塞的预防方面达比加群不劣于华法林。Dabigatran在接下来的一年中被FDA批准用于该适应症。</p>
<p>Rivaroxaban是第一种上市的因子Xa直接抑制剂。</p>
<p>2008年至2009年期间发表的RECORD
I-IV试验显示，利伐沙班在预防全髋关节或膝关节置换术后VTE方面优于依诺肝素。</p>
<p>随后分别于2010年和2012年发表的EINSTEIN-DVT和EINSTEIN-PE试验显示，利伐沙班在VTE治疗方面不劣于依诺肝素或华法林。</p>
<p>2011年，ROCKET-AF试验表明，在中度至高度卒中风险的房颤患者的卒中和全身性栓塞预防中，利伐沙班不劣于华法林。利伐沙班(Rivaroxaban)于2011年获得FDA批准用于房颤和VTE预防患者的卒中预防。</p>
<blockquote>
<p>Rivaroxaban was approved by the FDA in 2011 for both stroke
prevention in AF and VTE prophylaxis.</p>
</blockquote>
<p>阿哌沙班(Apixaban)是另一种因子Xa的直接拮抗剂。</p>
<p>对2009-2010年发表的三项ADVANCE试验表明，与依诺肝素相比，阿哌沙班降低了VTE发生率和全因死亡率。</p>
<p>2014年，Ⅲ期AMPLIFY试验发现，阿哌沙班治疗急性VTE不劣于依诺肝素或华法林。</p>
<p>在AF的卒中预防方面，2011年ARISTOTLE试验显示，阿哌沙班在房颤患者的卒中预防方面优于华法林，且出血事件减少。</p>
<p>此后，阿哌沙班(Apixaban)已被FDA批准用于所有这三种适应症。</p>
<p>Edoxaban是正在研究的VTE预防和治疗的最新因子Xa直接抑制剂。</p>
<p>2014年发表的Ⅲ期STARS-E3和STARS-J5试验显示，依度沙班(Edoxaban)预防全膝关节或髋关节置换术后血栓形成的效果不劣于依诺肝素，安全性相似。</p>
<p>2013年Hokusai-VTE试验是迄今为止规模最大的VTE试验，结果表明，依度沙班治疗复发性症状性VTE不劣于华法林。</p>
<p>ENGAGE-TIMI 48试验显示，依度沙班预防房颤患者(&gt;
20,000例)卒中方面不劣于华法林。根据ENGAGE-TIMI
48试验的结果，Edoxaban也已经获得FDA批准用于房颤的卒中预防。</p>
<p>总之，这些新的凝血酶和因子Xa的直接抑制剂已经克服了传统VKA的许多实践限制，并且许多临床试验表明它们对于VTE预防和治疗以及AF的卒中预防具有至少相似的效果。此外，这些NOAC似乎与较少的大出血事件有关。</p>
<p>人们迫切期待在未经选择、年龄较大且患有较多合并症患者中使用这些NOAC的相关数据。</p>

    </div>

    
    
    

      <footer class="post-footer">
          <div class="post-tags">
              <a href="/tags/%E5%88%A9%E4%BC%90%E6%B2%99%E7%8F%AD/" rel="tag"># 利伐沙班</a>
              <a href="/tags/%E8%BE%BE%E6%AF%94%E5%8A%A0%E7%BE%A4/" rel="tag"># 达比加群</a>
              <a href="/tags/%E9%98%BF%E5%93%8C%E6%B2%99%E7%8F%AD/" rel="tag"># 阿哌沙班</a>
              <a href="/tags/%E4%BE%9D%E5%BA%A6%E6%B2%99%E7%8F%AD/" rel="tag"># 依度沙班</a>
              <a href="/tags/NOAC/" rel="tag"># NOAC</a>
          </div>

        


        
    <div class="post-nav">
      <div class="post-nav-item">
    <a href="/2019/01/04/Ximelagatran-sets-the-stage-for-NOACs/" rel="prev" title="抗凝药物发展史中的14个里程碑（九）：希美加群为NOAC绽放奠定基础">
      <i class="fa fa-chevron-left"></i> 抗凝药物发展史中的14个里程碑（九）：希美加群为NOAC绽放奠定基础
    </a></div>
      <div class="post-nav-item">
    <a href="/2019/01/04/Quest-to-find-the-optimal-duration/" rel="next" title="抗凝药物发展史中的14个里程碑（十一）：寻求最佳VTE抗凝疗程">
      抗凝药物发展史中的14个里程碑（十一）：寻求最佳VTE抗凝疗程 <i class="fa fa-chevron-right"></i>
    </a></div>
    </div>
      </footer>
    
  </article>
  
  
  



          </div>
          

<script>
  window.addEventListener('tabs:register', () => {
    let { activeClass } = CONFIG.comments;
    if (CONFIG.comments.storage) {
      activeClass = localStorage.getItem('comments_active') || activeClass;
    }
    if (activeClass) {
      let activeTab = document.querySelector(`a[href="#comment-${activeClass}"]`);
      if (activeTab) {
        activeTab.click();
      }
    }
  });
  if (CONFIG.comments.storage) {
    window.addEventListener('tabs:click', event => {
      if (!event.target.matches('.tabs-comment .tab-content .tab-pane')) return;
      let commentClass = event.target.classList[1];
      localStorage.setItem('comments_active', commentClass);
    });
  }
</script>

        </div>
          
  
  <div class="toggle sidebar-toggle">
    <span class="toggle-line toggle-line-first"></span>
    <span class="toggle-line toggle-line-middle"></span>
    <span class="toggle-line toggle-line-last"></span>
  </div>

  <aside class="sidebar">
    <div class="sidebar-inner">

      <ul class="sidebar-nav motion-element">
        <li class="sidebar-nav-toc">
          文章目录
        </li>
        <li class="sidebar-nav-overview">
          站点概览
        </li>
      </ul>

      <!--noindex-->
      <div class="post-toc-wrap sidebar-panel">
      </div>
      <!--/noindex-->

      <div class="site-overview-wrap sidebar-panel">
        <div class="site-author motion-element" itemprop="author" itemscope itemtype="http://schema.org/Person">
  <p class="site-author-name" itemprop="name">Louyan</p>
  <div class="site-description" itemprop="description"></div>
</div>
<div class="site-state-wrap motion-element">
  <nav class="site-state">
      <div class="site-state-item site-state-posts">
          <a href="/archives/">
        
          <span class="site-state-item-count">466</span>
          <span class="site-state-item-name">日志</span>
        </a>
      </div>
      <div class="site-state-item site-state-categories">
            <a href="/categories/">
          
        <span class="site-state-item-count">17</span>
        <span class="site-state-item-name">分类</span></a>
      </div>
      <div class="site-state-item site-state-tags">
            <a href="/tags/">
          
        <span class="site-state-item-count">1693</span>
        <span class="site-state-item-name">标签</span></a>
      </div>
  </nav>
</div>



      </div>

    </div>
  </aside>
  <div id="sidebar-dimmer"></div>


      </div>
    </main>

    <footer class="footer">
      <div class="footer-inner">
        

        

<div class="copyright">
  
  &copy; 
  <span itemprop="copyrightYear">2022</span>
  <span class="with-love">
    <i class="fa fa-heart"></i>
  </span>
  <span class="author" itemprop="copyrightHolder">Louyan</span>
</div>
  <div class="powered-by">由 <a href="https://hexo.io/" class="theme-link" rel="noopener" target="_blank">Hexo</a> & <a href="https://muse.theme-next.org/" class="theme-link" rel="noopener" target="_blank">NexT.Muse</a> 强力驱动
  </div>

        








      </div>
    </footer>
  </div>

  
  <script src="/lib/anime.min.js"></script>
  <script src="/lib/velocity/velocity.min.js"></script>
  <script src="/lib/velocity/velocity.ui.min.js"></script>

<script src="/js/utils.js"></script>

<script src="/js/motion.js"></script>


<script src="/js/schemes/muse.js"></script>


<script src="/js/next-boot.js"></script>




  




  
<script src="/js/local-search.js"></script>













  

  

  

</body>
</html>
